FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038962741> ?p ?o ?g. }

• W2038962741 endingPage "281" @default.
• W2038962741 startingPage "273" @default.
• W2038962741 abstract "Patients with borderline resectable pancreatic cancer (BRPC) have a higher probability of undergoing margin-negative resection after completing neoadjuvant therapy. Here, we describe a novel neoadjuvant approach using induction chemotherapy followed by stereotactic body radiation therapy (SBRT) for patients with BRPC. This analysis included patients with nonmetastatic BRPC treated with neoadjuvant gemcitabine-based chemotherapy and five-fraction SBRT. Chemotherapy consisted of 3 cycles of Gemzar, Taxotere, and Xeloda. Patients were restaged to determine resectability, and nonmetastatic resectable patients underwent surgical resection. Thirty patients completed neoadjuvant treatment and were offered surgical exploration. Seventeen patients (56.7 %) reported no acute adverse effects during SBRT. No grade 3 or higher toxicity was observed from SBRT. Twenty-nine patients (96.7 %) underwent exploration. Twenty-one (95.6 %) of those who underwent pancreatic tumor resection achieved negative margins, with none requiring vessel resection. One (3.3 %) patient was resected with microscopic positive margins. Median follow-up was 15.6 months (range, 6.3–26.1 months). Median and 1-year overall survival was 20 months and 91 %, respectively. Median and 1-year progression-free survival was 14.9 months and 61 %, respectively. SBRT-based neoadjuvant therapy for BRPC is well tolerated and can result in a high rate of margin-negative tumor resection." @default.
• W2038962741 created "2016-06-24" @default.
• W2038962741 creator A5006838528 @default.
• W2038962741 creator A5012399386 @default.
• W2038962741 creator A5029626497 @default.
• W2038962741 creator A5035589941 @default.
• W2038962741 creator A5041857603 @default.
• W2038962741 creator A5046114953 @default.
• W2038962741 creator A5047712976 @default.
• W2038962741 creator A5062142011 @default.
• W2038962741 creator A5083490348 @default.
• W2038962741 creator A5084768389 @default.
• W2038962741 date "2012-05-30" @default.
• W2038962741 modified "2023-09-26" @default.
• W2038962741 title "Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline resectable pancreatic cancer" @default.
• W2038962741 cites W171510207 @default.
• W2038962741 cites W1972054401 @default.
• W2038962741 cites W1974219858 @default.
• W2038962741 cites W1981905971 @default.
• W2038962741 cites W1990948088 @default.
• W2038962741 cites W2000918206 @default.
• W2038962741 cites W2003032215 @default.
• W2038962741 cites W2017461673 @default.
• W2038962741 cites W2024418047 @default.
• W2038962741 cites W2035309840 @default.
• W2038962741 cites W2050023459 @default.
• W2038962741 cites W2050575833 @default.
• W2038962741 cites W2050643752 @default.
• W2038962741 cites W2050957719 @default.
• W2038962741 cites W2051462953 @default.
• W2038962741 cites W2059020621 @default.
• W2038962741 cites W2068359620 @default.
• W2038962741 cites W2074190642 @default.
• W2038962741 cites W2075527167 @default.
• W2038962741 cites W2079934168 @default.
• W2038962741 cites W2091405318 @default.
• W2038962741 cites W2095695135 @default.
• W2038962741 cites W2098571411 @default.
• W2038962741 cites W2104930742 @default.
• W2038962741 cites W2119914737 @default.
• W2038962741 cites W2126647813 @default.
• W2038962741 cites W2139103316 @default.
• W2038962741 cites W2146974261 @default.
• W2038962741 cites W2158734599 @default.
• W2038962741 cites W2166459387 @default.
• W2038962741 cites W2172087239 @default.
• W2038962741 cites W2238818897 @default.
• W2038962741 cites W2332462102 @default.
• W2038962741 cites W4247785462 @default.
• W2038962741 cites W4253769310 @default.
• W2038962741 cites W4253922044 @default.
• W2038962741 doi "https://doi.org/10.1007/s13566-012-0039-6" @default.
• W2038962741 hasPublicationYear "2012" @default.
• W2038962741 type Work @default.
• W2038962741 sameAs 2038962741 @default.
• W2038962741 citedByCount "12" @default.
• W2038962741 countsByYear W20389627412013 @default.
• W2038962741 countsByYear W20389627412014 @default.
• W2038962741 countsByYear W20389627412015 @default.
• W2038962741 countsByYear W20389627412016 @default.
• W2038962741 countsByYear W20389627412017 @default.
• W2038962741 countsByYear W20389627412018 @default.
• W2038962741 countsByYear W20389627412020 @default.
• W2038962741 countsByYear W20389627412021 @default.
• W2038962741 crossrefType "journal-article" @default.
• W2038962741 hasAuthorship W2038962741A5006838528 @default.
• W2038962741 hasAuthorship W2038962741A5012399386 @default.
• W2038962741 hasAuthorship W2038962741A5029626497 @default.
• W2038962741 hasAuthorship W2038962741A5035589941 @default.
• W2038962741 hasAuthorship W2038962741A5041857603 @default.
• W2038962741 hasAuthorship W2038962741A5046114953 @default.
• W2038962741 hasAuthorship W2038962741A5047712976 @default.
• W2038962741 hasAuthorship W2038962741A5062142011 @default.
• W2038962741 hasAuthorship W2038962741A5083490348 @default.
• W2038962741 hasAuthorship W2038962741A5084768389 @default.
• W2038962741 hasBestOaLocation W20389627411 @default.
• W2038962741 hasConcept C121608353 @default.
• W2038962741 hasConcept C126322002 @default.
• W2038962741 hasConcept C126838900 @default.
• W2038962741 hasConcept C141071460 @default.
• W2038962741 hasConcept C143998085 @default.
• W2038962741 hasConcept C2776694085 @default.
• W2038962741 hasConcept C2778292576 @default.
• W2038962741 hasConcept C2780140570 @default.
• W2038962741 hasConcept C2780210213 @default.
• W2038962741 hasConcept C2780258809 @default.
• W2038962741 hasConcept C509974204 @default.
• W2038962741 hasConcept C530470458 @default.
• W2038962741 hasConcept C71924100 @default.
• W2038962741 hasConceptScore W2038962741C121608353 @default.
• W2038962741 hasConceptScore W2038962741C126322002 @default.
• W2038962741 hasConceptScore W2038962741C126838900 @default.
• W2038962741 hasConceptScore W2038962741C141071460 @default.
• W2038962741 hasConceptScore W2038962741C143998085 @default.
• W2038962741 hasConceptScore W2038962741C2776694085 @default.
• W2038962741 hasConceptScore W2038962741C2778292576 @default.
• W2038962741 hasConceptScore W2038962741C2780140570 @default.
• W2038962741 hasConceptScore W2038962741C2780210213 @default.

• next